Literature DB >> 6629132

Vaccination with SolcoTrichovac. Immunological aspects of a new approach for therapy and prophylaxis of trichomoniasis in women.

R Pavic, L Stojković.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6629132

Source DB:  PubMed          Journal:  Gynakol Rundsch        ISSN： 0017-6001


× No keyword cloud information.
  3 in total

Review 1.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis.

Authors:  A Gombosová; P Demes; M Valent
Journal:  Genitourin Med       Date:  1986-04

3.  Does lactobacillus vaccine for trichomoniasis, Solco Trichovac, induce antibody reactive with Trichomonas vaginalis?

Authors:  J F Alderete
Journal:  Genitourin Med       Date:  1988-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.